| SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance? P Guisado Hernández, P Blanco Lobo, I Villaoslada, B de Felipe, ... Journal of Clinical Immunology 41 (7), 1502-1506, 2021 | 19 | 2021 |
| Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant P Blanco Lobo, WT Lei, SJ Pelham, P Guisado Hernández, I Villaoslada, ... Pediatric Allergy and Immunology 32 (8), 1804-1812, 2021 | 11 | 2021 |
| Ex vivo effect of JAK inhibition on JAK-STAT1 pathway hyperactivation in patients with dominant-negative STAT3 mutations PB Lobo, P Guisado-Hernández, I Villaoslada, B de Felipe, C Carreras, ... Journal of Clinical Immunology 42 (6), 1193-1204, 2022 | 9 | 2022 |
| Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma B Parejo-Alonso, A Royo-García, P Espiau-Romera, S Courtois, ... Biomedicine & Pharmacotherapy 158, 114162, 2023 | 6 | 2023 |
| Ex vivo effect of JAK inhibition on JAK-STAT1 pathway hyperactivation in patients with dominant negative STAT3 mutations O Neth, PB Lobo, PG Hernández, IV Casaled, B de Felipe Carrillo, ... | | 2022 |
| ALK signaling drives tumorigenicity and chemoresistance of pancreatic ductal adenocarcinoma cells B Parejo-Alonso, A Royo-Garcia, P Espiau-Romera, S Courtois, ... bioRxiv, 2022.08. 29.505637, 2022 | | 2022 |
| TRAF3IP2 variants in a child with chronic mucocutaneous candidiasis-keeping an open mind! PB Lobo, WT Lei, S Pelham, PG Hernández, I Villaoslada, B de Felipe, ... Authorea Preprints, 2021 | | 2021 |
| Double Trouble: a patient with STAT1 GOF and Down Syndrome IV Casaled, PG Hernández, PB Lobo, B De Felipe, P Olbrich, O Neth Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología …, 2021 | | 2021 |
